Количество 2
Количество 2
CVE-2017-17678
больше 4 лет назад
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
CVSS3: 6.1
EPSS: Низкий
GHSA-w2cx-4cp9-hmm4
больше 3 лет назад
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
EPSS: Низкий
Уязвимостей на страницу
20
Уязвимость | CVSS | EPSS | Опубликовано | |
|---|---|---|---|---|
 | CVE-2017-17678 BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility. | CVSS3: 6.1 | 0% Низкий | больше 4 лет назад |
| GHSA-w2cx-4cp9-hmm4 BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility. | 0% Низкий | больше 3 лет назад |
Уязвимостей на страницу
20